Why the study?
Does moricizine reduce runs of nonsustained VT and prevent recurrence of sustained VT in patients with ventricular tachycardia?
Population
50 patients with 10 or more runs of nonsustained ventricular tachycardia on a screening 24 hr ambulatory ECG…
Comparison
Moricizine averaging 10 mg/kg/day vs Placebo
Design
Other, single-blind
Authors
Loading...
Moricizine may suppress nonsustained VT without preventing sustained recurrences; hypothesis-generating and should not change practice.
Does moricizine reduce runs of nonsustained VT and prevent recurrence of sustained VT in patients with ventricular tachycardia?
Moricizine effectively reduces nonsustained ventricular tachycardia but fails to prevent the recurrence of sustained ventricular tachycardia.
Pratt et al. (1986) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: